2y68
From Proteopedia
(Difference between revisions)
(6 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | [[Image:2y68.png|left|200px]] | ||
- | < | + | ==Structure-based design of a new series of D-glutamic acid-based inhibitors of bacterial MurD ligase== |
- | + | <StructureSection load='2y68' size='340' side='right'caption='[[2y68]], [[Resolution|resolution]] 1.49Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[2y68]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_K-12 Escherichia coli K-12]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2Y68 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2Y68 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.49Å</td></tr> | |
- | -- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AZI:AZIDE+ION'>AZI</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=KCX:LYSINE+NZ-CARBOXYLIC+ACID'>KCX</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=T04:2-[[2-FLUORO-5-[[[4-[(Z)-(4-OXO-2-SULFANYLIDENE-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]PHENYL]AMINO]METHYL]PHENYL]CARBONYLAMINO]PENTANEDIOIC+ACID'>T04</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2y68 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2y68 OCA], [https://pdbe.org/2y68 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2y68 RCSB], [https://www.ebi.ac.uk/pdbsum/2y68 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2y68 ProSAT]</span></td></tr> | |
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/MURD_ECOLI MURD_ECOLI] Cell wall formation. Catalyzes the addition of glutamate to the nucleotide precursor UDP-N-acetylmuramoyl-L-alanine (UMA).[HAMAP-Rule:MF_00639] | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | MurD ligase is one of the key enzymes participating in the intracellular steps of peptidoglycan biosynthesis and constitutes a viable target in the search for novel antibacterial drugs to combat bacterial drug-resistance. We have designed, synthesized, and evaluated a new series of d-glutamic acid-based Escherichia coli MurD inhibitors incorporating the 5-benzylidenethiazolidin-4-one scaffold. The crystal structure of 16 in the MurD active site has provided a good starting point for the design of structurally optimized inhibitors 73-75 endowed with improved MurD inhibitory potency (IC(50) between 3 and 7 muM). Inhibitors 74 and 75 showed weak activity against Gram-positive Staphylococcus aureus and Enterococcus faecalis. Compounds 73-75, with IC(50) values in the low micromolar range, represent the most potent d-Glu-based MurD inhibitors reported to date. | ||
- | + | Structure-Based Design of a New Series of d-Glutamic Acid Based Inhibitors of Bacterial UDP-N-acetylmuramoyl-l-alanine:d-glutamate Ligase (MurD).,Tomasic T, Zidar N, Sink R, Kovac A, Blanot D, Contreras-Martel C, Dessen A, Muller-Premru M, Zega A, Gobec S, Kikelj D, Peterlin Masic L J Med Chem. 2011 Jun 3. PMID:21591605<ref>PMID:21591605</ref> | |
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 2y68" style="background-color:#fffaf0;"></div> | ||
- | + | ==See Also== | |
- | + | *[[Mur ligase|Mur ligase]] | |
- | + | == References == | |
- | + | <references/> | |
- | + | __TOC__ | |
- | + | </StructureSection> | |
- | == | + | [[Category: Escherichia coli K-12]] |
- | [[ | + | [[Category: Large Structures]] |
- | + | [[Category: Blanot D]] | |
- | == | + | [[Category: Contreras-Martel C]] |
- | < | + | [[Category: Dessen A]] |
- | [[Category: Escherichia coli]] | + | [[Category: Gobec S]] |
- | [[Category: | + | [[Category: Kikelj D]] |
- | [[Category: Blanot | + | [[Category: Kovac A]] |
- | [[Category: Contreras-Martel | + | [[Category: Muller-Premru M]] |
- | [[Category: Dessen | + | [[Category: Patin D]] |
- | [[Category: Gobec | + | [[Category: Peterlin-Masic L]] |
- | [[Category: Kikelj | + | [[Category: Sink R]] |
- | [[Category: Kovac | + | [[Category: Tomasic T]] |
- | [[Category: Muller-Premru | + | [[Category: Zega A]] |
- | [[Category: Patin | + | [[Category: Zidar N]] |
- | [[Category: Peterlin-Masic | + | |
- | [[Category: Sink | + | |
- | [[Category: Tomasic | + | |
- | [[Category: Zega | + | |
- | [[Category: Zidar | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Structure-based design of a new series of D-glutamic acid-based inhibitors of bacterial MurD ligase
|
Categories: Escherichia coli K-12 | Large Structures | Blanot D | Contreras-Martel C | Dessen A | Gobec S | Kikelj D | Kovac A | Muller-Premru M | Patin D | Peterlin-Masic L | Sink R | Tomasic T | Zega A | Zidar N